Brief: Zentalis Pharmaceuticals Q3 EPS USD -0.79
06/11/2023 12:19
Nov 06 (Reuters) - Zentalis Pharmaceuticals Q3 operating income USD -62.718 million. * Q3 pretax profit USD -55.509 million * Q3 operating expenses USD 62.718 million * Q3 net income USD -55.54 million
Recent news on Zentalis Pharmaceuticals
See all newsBrief: Zentalis Pharmaceuticals Says Median Overall Survival Of 15.8 Months With Azenosertib In Cyclin E1-Positive Proc
Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer